What is the Coupang Inc (CPNG) price today?

The price of Coupang Inc (CPNG) today is $16.32. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/CPNG

Us company

Coupang Inc (CPNG) Stock Price Today

Technicals Fundamentals Financials News Corp Action About Compare

24H

YTD

Aura AI Summary

Coupang (CPNG) trades at $16.29, down 1.27% on the day, with a neutral technical signal and bearish moving averages. The company reported revenue of $34.53B in 2025 with a net income of $208M, but recent quarterly earnings have missed expectations. Positive cash flow from operations of $1.77B in 2025 supports ongoing investments, while analyst consensus remains strongly bullish with a $23.38 price target.

The outlook is mixed: strong revenue growth and dominant market position in South Korea offer upside, but consecutive earnings misses, negative net income margin, and high valuation ratios pose risks. Expansion into Taiwan and AI investments present growth catalysts, though regulatory fines and competitive pressures require monitoring.

Read full analysis

Key Stats

Market Cap
$29.34B
Volume
-
Sector
Consumer Cyclical
52W High
$33.53
52W Low
$15.12
Typical Hold Time
-
Enterprise Value
$28.86B
Div Yield
-
Trading Activity
-

$16.32

52W Low: $15.12

10 Jun 2026

52W High: $33.53

17 Sep 2025

Track Coupang Inc (CPNG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Coupang Inc has traded between a low of $15.12 and a high of $33.53, highlighting its annual price range. Buy and sell Coupang Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Coupang Inc

Coupang Inc is an e-commerce company. The company sells apparel, electronics, footwear, food products, furniture, nutritional supplements, and other products. Its segments include Product Commerce and Growth Initiatives.

Most Recent News

Content is generated by Aura AI

Stocks fall sharply amid fraud probe and mixed earnings, with Cellebrite down 29%.

Several stocks dropped significantly today due to various company-specific issues. Cellebrite DI Ltd. plunged 29.18% following a securities fraud investigation, while Securitize Corp. fell 27.48% despite a major NYSE listing milestone. Liftoff Mobile...

Altimmune CEO buys shares, signaling confidence amid strong Q2 results and MASH drug progress.

Altimmune's CEO recently purchased 15,000 shares at $2.95 each, showing strong leadership confidence in the company's future. The biopharmaceutical firm reported a better-than-expected Q2 loss of $0.12 per share and holds $519 million in cash, securi...

H.B. Fuller sees revenue gains but faces uncertainty from acquisitions and potential asset sale

H.B. Fuller Company remains a Buy candidate due to recent improvements in revenue and profitability despite past challenges. The acquisition of Advanced Medical Solutions Group expands its market by $15 billion but increases debt and depends on achie...

Catch up fast with Aura AI

Get an AI-generated news summary for this asset in seconds.

Frequently Asked Questions

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

Are US Stocks safe?

Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

Market Cap
$29.34B
Volume
-
Sector
Consumer Cyclical
52W High
$33.53
52W Low
$15.12
Typical Hold Time
-
Enterprise Value
$28.86B
Div Yield
-
Trading Activity
-

$16.32

52W Low: $15.12

10 Jun 2026

52W High: $33.53

17 Sep 2025

Let’s invest in this asset by signing up or download!

Coupang Inc (CPNG) Stock Price Today

Aura AI Summary

Key Stats

About Coupang Inc

Most Recent News

Stocks fall sharply amid fraud probe and mixed earnings, with Cellebrite down 29%.

Altimmune CEO buys shares, signaling confidence amid strong Q2 results and MASH drug progress.

H.B. Fuller sees revenue gains but faces uncertainty from acquisitions and potential asset sale

People also bought

Frequently Asked Questions

Key Stats

Invest

Features

Fees

Learn

Tools

Support

iOS App Store

Google Play Store